2nd Cancer Professional Training Session [Webinar Open to the Public]
"'Anticancer Drugs' Are 'Carcinogenic'!—When Using Anticancer Drugs, Are Family Members at Risk? Are Countermeasures Necessary?" Toshiaki Nakayama (Deputy Chief Pharmacist, Department of Pharmacy, Saitama Cancer Center)
I want to apply what I've learned in the future, not only by focusing on medication adherence for individual patients but also by considering the importance of lifestyle and being mindful of their emotional well-being. (Pharmacist, 40s)
I participated because I wanted the nurses at our hospital to understand this topic, and I felt the lecture explained things in a way that would be necessary and understandable for nurses too. (Pharmacist, 30s)
It was very easy to understand. The session covered not only the exposure of healthcare professionals but also specific methods for instructing patients and their families, which will be helpful in my work. (Pharmacist, 50s)
As I am involved in home healthcare, I believe I can use this information to guide patients in their homes. (Pharmacist, 40s)
This was the first time I had heard the term 'exposure to anticancer drugs.' I have an acquaintance who is on anticancer medication, so I was aware of side effects and the risk of secondary cancers. While I learned that the general public doesn't need to worry about exposure, it made me feel that we must be grateful to the healthcare professionals who handle these drugs. (Office worker, 40s)
Since this was a public lecture, the speaker used simple terms that were easy for non-healthcare professionals to follow, which made it very understandable. There was also a lot of valuable information that will be useful for the discharge support I provide daily. I learned a great deal. (Medical social worker, 30s)
1st Cancer Professional Training Session
"The Practice of Pharmaceutical Care for Patients Using Immune Checkpoint Inhibitors"
It was great that we moved into the group discussion early, allowing everyone to actively express their opinions. I also learned a lot as the facilitators guided us to consider a broader perspective.
I learned a great deal by listening to the hospital pharmacists during the group discussion. It was a rewarding experience to hear about clinical situations that you can't learn from books alone. I am eager to learn more.
I learned a great deal, not just about irAE management, but also about the importance of viewing patients from multiple perspectives when monitoring drug therapy, and it helped me recognize perspectives I was lacking.